Technology: Biotechnology, CAR-T, CAR-T therapy, Cell-based gene therapy, Cell_Therapies, Health Care, Medical, Pharmaceutical, Stem cell therapy
Industry: AI, Pharma, Public
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 1996-01-01
Employees Number: 10001+
Funding Status: IPO
Investor Type: Accelerator
Investment Stage: N/A
Number Of Exits: 21
Acquisitions Number: 25
Investors Number: 1
Total Funding: 6500000
Estimated Revenue: $10B+
Last Funding Date: 2018-02-14
Last Funding Type: Grant

Visit Website
Register and Claim Ownership